Abstract
Objective: To investigate recanalisation in the first 12 months after cerebral venous thrombosis.
Methods: 33 consecutive patients presenting with cerebral venous thrombosis were enrolled in the study. Diagnosis was made by magnetic resonance imaging (MRI) and magnetic resonance venography (MRV) or catheter angiography. Patients were initially treated with intravenous heparin. Warfarin was given for at least four months. Cerebral MRI and MRV were done at four months and repeated after 12 months if venous thrombosis persisted. Outcome was evaluated by the Rankin scale at 12 months.
Results: Outcome at 12 months was good, with a median modified Rankin scale score of 0 (range 0 to 2); 27 patients (82%) had no residual deficits. No patient suffered recurrent cerebral venous thrombosis, deep vein thrombosis, or pulmonary embolism during follow up. After four months, all deep cerebral veins and cavernous sinuses, 94% of superior sagittal sinuses, 80% of straight sinuses, 73% of jugular veins, 58% of transverse sinuses, and 41% of sigmoid sinuses had recanalised. No further recanalisation was observed thereafter.
Conclusions: The results suggest that recanalisation only occurs within the first four months following cerebral venous thrombosis and not thereafter, irrespective of oral anticoagulation.
Full Text
The Full Text of this article is available as a PDF (71.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Charbonnier B. A., Fiessinger J. N., Banga J. D., Wenzel E., d'Azemar P., Sagnard L. Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. FRAXODI group. Thromb Haemost. 1998 May;79(5):897–901. [PubMed] [Google Scholar]
- Einhäupl K. M., Villringer A., Meister W., Mehraein S., Garner C., Pellkofer M., Haberl R. L., Pfister H. W., Schmiedek P. Heparin treatment in sinus venous thrombosis. Lancet. 1991 Sep 7;338(8767):597–600. doi: 10.1016/0140-6736(91)90607-q. [DOI] [PubMed] [Google Scholar]
- Koopman M. M., Prandoni P., Piovella F., Ockelford P. A., Brandjes D. P., van der Meer J., Gallus A. S., Simonneau G., Chesterman C. H., Prins M. H. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group. N Engl J Med. 1996 Mar 14;334(11):682–687. doi: 10.1056/NEJM199603143341102. [DOI] [PubMed] [Google Scholar]
- Mattle H. P., Wentz K. U., Edelman R. R., Wallner B., Finn J. P., Barnes P., Atkinson D. J., Kleefield J., Hoogewoud H. M. Cerebral venography with MR. Radiology. 1991 Feb;178(2):453–458. doi: 10.1148/radiology.178.2.1987608. [DOI] [PubMed] [Google Scholar]
- Mattle H., Edelman R. R., Reis M. A., Atkinson D. J. Flow quantification in the superior sagittal sinus using magnetic resonance. Neurology. 1990 May;40(5):813–815. doi: 10.1212/wnl.40.5.813. [DOI] [PubMed] [Google Scholar]
- Preter M., Tzourio C., Ameri A., Bousser M. G. Long-term prognosis in cerebral venous thrombosis. Follow-up of 77 patients. Stroke. 1996 Feb;27(2):243–246. doi: 10.1161/01.str.27.2.243. [DOI] [PubMed] [Google Scholar]
- Schulman S., Rhedin A. S., Lindmarker P., Carlsson A., Lärfars G., Nicol P., Loogna E., Svensson E., Ljungberg B., Walter H. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med. 1995 Jun 22;332(25):1661–1665. doi: 10.1056/NEJM199506223322501. [DOI] [PubMed] [Google Scholar]
- de Bruijn S. F., Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke. 1999 Mar;30(3):484–488. doi: 10.1161/01.str.30.3.484. [DOI] [PubMed] [Google Scholar]
- van Swieten J. C., Koudstaal P. J., Visser M. C., Schouten H. J., van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988 May;19(5):604–607. doi: 10.1161/01.str.19.5.604. [DOI] [PubMed] [Google Scholar]